Literature DB >> 27196732

Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?

Kris Huygen1.   

Abstract

Entities:  

Keywords:  diphtheria; equine diphtheria antitoxin

Mesh：

Substances：

Year:  2016        PMID： 27196732      PMCID： PMC4991321          DOI： 10.1080/21505594.2016.1190062

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  10 in total

1.  Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

Authors:  H Theeten; V Hutse; N Hens; Y Yavuz; K Hoppenbrouwers; P Beutels; R Vranckx; P Van Damme
Journal:  Epidemiol Infect       Date:  2010-06-29       Impact factor: 2.451

2.  Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin.

Authors:  Mai Kakita; Tsuyoshi Takahashi; Takako Komiya; Yoshitaka Iba; Takao Tsuji; Yoshikazu Kurosawa; Motohide Takahashi
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 3.  A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use.

Authors:  K S Wagner; P Stickings; J M White; S Neal; N S Crowcroft; D Sesardic; A Efstratiou
Journal:  Vaccine       Date:  2009-10-07       Impact factor: 3.641

4.  Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women.

Authors:  Kris Huygen; Raïssa Nadège Caboré; Kirsten Maertens; Pierre Van Damme; Elke Leuridan
Journal:  Vaccine       Date:  2015-07-14       Impact factor: 3.641

5.  The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.

Authors:  W J Edmunds; R G Pebody; H Aggerback; S Baron; G Berbers; M A Conyn-van Spaendonck; H O Hallander; R Olander; P A Maple; H E Melker; P Olin; F Fievret-Groyne; C Rota; S Salmaso; A Tischer; C von-Hunolstein; E Miller
Journal:  Epidemiol Infect       Date:  2000-08       Impact factor: 2.451

6.  Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study.

Authors:  Kirsten Maertens; Raïssa Nadège Caboré; Kris Huygen; Niel Hens; Pierre Van Damme; Elke Leuridan
Journal:  Vaccine       Date:  2015-11-16       Impact factor: 3.641

7.  Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication.

Authors:  Leila M Sevigny; Brian J Booth; Kirk J Rowley; Brett A Leav; Peter S Cheslock; Kerry A Garrity; Susan E Sloan; William Thomas; Gregory J Babcock; Yang Wang
Journal:  Infect Immun       Date:  2013-08-12       Impact factor: 3.441

8.  Diphtheria in the postepidemic period, Europe, 2000-2009.

Authors:  Karen S Wagner; Joanne M White; Irina Lucenko; David Mercer; Natasha S Crowcroft; Shona Neal; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

9.  Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.

Authors:  E M Swart; P G M van Gageldonk; H E de Melker; F R van der Klis; G A M Berbers; L Mollema
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

10.  Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model.

Authors:  Heidi L Smith; Peter Cheslock; Mark Leney; Bruce Barton; Deborah C Molrine
Journal:  Virulence       Date:  2016-04-12       Impact factor: 5.882
  10 in total
  3 in total

1.  Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium.

Authors:  Raïssa Nadège Caboré; Kirsten Maertens; Alexandre Dobly; Elke Leuridan; Pierre Van Damme; Kris Huygen
Journal:  Virulence       Date:  2017-02-22       Impact factor: 5.882

Review 2.  Designing development programs for non-traditional antibacterial agents.

Authors:  John H Rex; Holly Fernandez Lynch; I Glenn Cohen; Jonathan J Darrow; Kevin Outterson
Journal:  Nat Commun       Date:  2019-07-31       Impact factor: 14.919

3.  Identification of a Type-Specific Epitope in the ORF2 Protein of Duck Astrovirus Type 1.

Authors:  Jingjing Lan; Ruihua Zhang; Pengfei Li; Junhao Chen; Zhijing Xie; Shijin Jiang
Journal:  Animals (Basel)       Date:  2019-12-02       Impact factor: 2.752
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.